Caries Research

Basic Science

Maltotriitol Inhibition of Maltose Metabolism in Streptococcus mutans via Maltose Transport, Amylomaltase and Phospho-α-Glucosidase Activities

Würsch P. · Koellreutter B.

Author affiliations

Research Department, Nestec Ltd., Vevey, Switzerland

Related Articles for ""

Caries Res 1985;19:439–449

Log in to MyKarger to check if you already have access to this content.


Buy

  • FullText & PDF
  • Unlimited re-access via MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

CHF 38.00 *
EUR 35.00 *
USD 39.00 *

Select

KAB

Buy a Karger Article Bundle (KAB) and profit from a discount!


If you would like to redeem your KAB credit, please log in.


Save over 20% compared to the individual article price.

Learn more

Rent/Cloud

  • Rent for 48h to view
  • Buy Cloud Access for unlimited viewing via different devices
  • Synchronizing in the ReadCube Cloud
  • Printing and saving restrictions apply

Rental: USD 8.50
Cloud: USD 20.00

Select

Subscribe

  • Access to all articles of the subscribed year(s) guaranteed for 5 years
  • Unlimited re-access via Subscriber Login or MyKarger
  • Unrestricted printing, no saving restrictions for personal use
read more

Subcription rates


Select
* The final prices may differ from the prices shown due to specifics of VAT rules.

Article / Publication Details

First-Page Preview
Abstract of Basic Science

Published online: November 18, 2009
Issue release date: 1985

Number of Print Pages: 11
Number of Figures: 0
Number of Tables: 0

ISSN: 0008-6568 (Print)
eISSN: 1421-976X (Online)

For additional information: https://www.karger.com/CRE

Abstract

Maltose glycolysis and transport in Streptococcus mutans OMZ 176 were shown to be inhibited by maltotriitol (MTL). The sugar alcohol was taken up, but was not metabolized. The phosphoenolpyruvate: maltose phosphotransferase (PEP:PTS) system activity was present in cells grown on glucose and maltose and was not inhibited by MTL. The product of the maltose PTS reaction was isolated and identified as maltose 6′-phosphate. The phospho-α-glucosidase induced by maltose hydrolyzed maltose phosphate into glucose and glucose 6-phosphate. The maltose-inducible amylomaltase which catalyses the transfer of both glucosyl and maltodextrinyl units was purified. The apparent Km for maltose was 21.8 mM. MTL inhibited the enzyme activity on maltose (Ki 2.0 mM) and maltotriose without being itself a substrate, but transglycosylation occurred on MTL when maltoheptaose was the donor substrate. These results indicated that in strain OMZ 176, maltose transport was mediated by a PEP-dependent maltose PTS yielding maltose 6′-phosphate which subsequently was hydrolyzed by a maltose-inducible phospho-α-glucosidase. It was suggested that MTL inhibits glycolysis of maltose by reducing the rate of maltose transport and inhibiting amylomaltase and phospho-α-glucosidase activities, resulting in an accumulation of maltose 6′-phosphate.

© 1985 S. Karger AG, Basel




Related Articles:


Article / Publication Details

First-Page Preview
Abstract of Basic Science

Published online: November 18, 2009
Issue release date: 1985

Number of Print Pages: 11
Number of Figures: 0
Number of Tables: 0

ISSN: 0008-6568 (Print)
eISSN: 1421-976X (Online)

For additional information: https://www.karger.com/CRE


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
TOP